Pharvaris (PHVS) Current Leases (2021 - 2026)
Pharvaris (PHVS) posted Current Leases of $241537.7 for Q1 2026, up 3.64% on a QoQ basis from $233056.6 in Q4 2025, and up 18.0% year-over-year from $204695.7 in Q1 2025.
Pharvaris (PHVS) Current Leases (2021 - 2026) Analysis & Trends
Pharvaris' Current Leases history runs 6 years deep, the most recent figure standing at $241537.7 for Q1 2026.
- Quarterly Current Leases rose 18.0% year-over-year to $241537.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241537.7 (up 18.0% YoY) and the FY2025 annual result came in at $226202.9, down 6.04% from the prior year.
- Current Leases was $241537.7 for Q1 2026 at Pharvaris, up from $233056.6 in the prior quarter.
- Across five years, Current Leases topped out at $248405.4 in Q2 2023 and bottomed at $104057.5 in Q2 2024.
- A 5-year average of $179872.2 and a median of $191198.4 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases surged 114.24% — and 2024, when it plunged 58.11%.
- Pharvaris' Current Leases stood at $191198.4 in 2022, then rose by 9.93% to $210175.2 in 2023, then grew by 13.09% to $237684.5 in 2024, then dropped by 1.95% to $233056.6 in 2025, then gained by 3.64% to $241537.7 in 2026.
- Business Quant data shows PHVS's Current Leases at $241537.7 in Q1 2026, $233056.6 in Q4 2025, and $160881.9 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | 241,537.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241,537.71 |
| Dec 31, 2025 | 233,056.64 |
| Sep 30, 2025 | 160,881.85 |
| Jun 30, 2025 | 182,861.30 |
| Mar 31, 2025 | 204,695.66 |
| Dec 31, 2024 | 237,684.47 |
| Sep 30, 2024 | 109,205.85 |
| Jun 30, 2024 | 104,057.49 |
| Mar 31, 2024 | 130,864.22 |
| Dec 31, 2023 | 210,175.18 |
| Sep 30, 2023 | 212,646.35 |
| Jun 30, 2023 | 248,405.43 |
| Mar 31, 2023 | 244,850.74 |
| Dec 31, 2022 | 191,198.44 |
| Sep 30, 2022 | 113,216.10 |
| Jun 30, 2022 | 118,200.00 |
| Mar 31, 2022 | 114,289.89 |
| Dec 31, 2021 | 113,747.32 |